These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 11219367)

  • 1. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
    Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
    Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
    Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
    Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
    Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
    J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.
    Lintzeris N; Strang J; Metrebian N; Byford S; Hallam C; Lee S; Zador D;
    Harm Reduct J; 2006 Sep; 3():28. PubMed ID: 17002810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.
    Oviedo-Joekes E; Sordo L; Guh D; Marsh DC; Lock K; Brissette S; Anis AH; Schechter MT
    Addict Behav; 2015 Feb; 41():81-6. PubMed ID: 25452049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.
    Marchand KI; Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Schechter MT
    BMC Health Serv Res; 2011 Jul; 11():174. PubMed ID: 21791093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
    Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
    Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.
    Marsch LA
    Addiction; 1998 Apr; 93(4):515-32. PubMed ID: 9684390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Chawarski MC; Zhou W; Schottenfeld RS
    Drug Alcohol Depend; 2011 Jun; 115(3):237-9. PubMed ID: 21159452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance in primary care: a randomized controlled trial.
    Fiellin DA; O'Connor PG; Chawarski M; Pakes JP; Pantalon MV; Schottenfeld RS
    JAMA; 2001 Oct; 286(14):1724-31. PubMed ID: 11594897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.